Advances in COVID-19 and Cancer

Dear Colleagues,

Since the end of 2019, physicians all over the world have faced the challenge of understanding a new and complex disease: COVID-19. Initially, COVID-19 was believed to be a primarily respiratory disease; however, it quickly emerged that the immune system was also involved. Inflammation was identified as a primary player in the pathogenesis of the various manifestations of this disease, and it also appears to play a role in more long-term consequences of infection, even in terms of inflammatory disorders. Another interesting aspect is the role of COVID-19 in patients who already presented with inflammatory disorders or immune disorders, many of whom experienced post-infective reacutizations.

People with cancer represent a large group of patients with immune alterations, either as a result of the tumor itself or the therapies the patient must undergo.

Articles for this Topic are required to assess the role of COVID-19 in cancer, both in its pathogenesis and its progression. Authors may also focus on the role of cancer in promoting COVID-19 infections, as well as its peculiar manifestations in this group of patients.

Dr. Laura Franza
Dr. Rossella Cianci
Topic Editors